Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015‐2016 season and comparison of HA mutations detected in Turkey since 2009

Influenza A(H1N1)pdm09 pandemic virus causing the 2009 global outbreak moved into the post‐pandemic period, but its variants continued to be the prevailing subtype in the 2015‐2016 influenza season in Europe and Asia. To determine the molecular characteristics of influenza A(H1N1)pdm09 isolates circ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical virology 2019-12, Vol.91 (12), p.2074-2082
Hauptverfasser: Guldemir, Dilek, Coskun‐Ari, Fatma Filiz, Altas, Ayse Basak, Bakkaloglu, Zekiye, Unaldi, Ozlem, Bayraktar, Fatma, Korukluoglu, Gulay, Aktas, Ali Riza, Durmaz, Riza
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2082
container_issue 12
container_start_page 2074
container_title Journal of medical virology
container_volume 91
creator Guldemir, Dilek
Coskun‐Ari, Fatma Filiz
Altas, Ayse Basak
Bakkaloglu, Zekiye
Unaldi, Ozlem
Bayraktar, Fatma
Korukluoglu, Gulay
Aktas, Ali Riza
Durmaz, Riza
description Influenza A(H1N1)pdm09 pandemic virus causing the 2009 global outbreak moved into the post‐pandemic period, but its variants continued to be the prevailing subtype in the 2015‐2016 influenza season in Europe and Asia. To determine the molecular characteristics of influenza A(H1N1)pdm09 isolates circulating during the 2015‐2016 season in Turkey, we identified mutations in the hemagglutinin (HA) genes and investigated the presence of H275Y alteration in the neuraminidase genes in the randomly selected isolates. The comparison of the HA nucleotide sequences revealed a very high homology (>99.5%) among the studied influenza A(H1N1)pdm09 isolates, while a relatively low homology (96.6%‐97.2%), was observed between Turkish isolates and the A/California/07/2009 vaccine virus. Overall 14 common mutations were detected in HA sequences of all 2015‐2016 influenza A(H1N1)pdm09 isolates with respect to the A/California/07/2009 virus, four of which located in three different antigenic sites. Eleven rare mutations in 12 HA sequences were also detected. Phylogenetic analysis revealed that all characterized influenza A(H1N1)pdm09 isolates formed a single genetic cluster, belonging to the genetic subclade 6B.1, defined by HA amino acid substitutions S84N, S162N, and I216T. Furthermore, all isolates showed an oseltamivir‐sensitive genotype, suggesting that Tamiflu (Oseltamivir) could still be the drug of choice in Turkey.
doi_str_mv 10.1002/jmv.25565
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2269395011</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2305845767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3535-f73a705ae2eb4f107bd6b31da383f9e2d84c7de50a393ed79e07a6f26411e00d3</originalsourceid><addsrcrecordid>eNp10UFu1DAYhmELgehQWHABZIlNu0j7247teDmqgAG1sClsLU_8R83gJIOdFE1XHIEzcLSepO6kdIHEypvHry19hLxmcMIA-Ommuz7hUir5hCwYGFUY0OwpWQArVaEUkwfkRUobAKgM58_JgWCiMiDkgvy5GALWU3CR1lcuunrE2N64sR16OjR0vELa9k2YsL9xdHm0Yp_Z8dZ3YGibhuBGTLQeQk6M6LPcX-DA5O2v3_lQNKFLOeV6n123dbFNc3m1pN007h9K1OP4WLic4nfc0dT29X0KzEvyrHEh4auH85B8ff_u8mxVnH_58PFseV7UQgpZNFo4DdIhx3XZMNBrr9aCeScq0Rjkvipr7VGCE0ag1wZBO9VwVTKGAF4ckqO5u43DjwnTaLs21RiC63GYkuVcGWEkMJbp23_oZphin39nuQBZlVIrndXxrOo4pBSxsdvYdi7uLAN7P5zNw9n9cNm-eShO6w79o_y7VAanM_jZBtz9v2Q_XXybk3fdTaHl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2305845767</pqid></control><display><type>article</type><title>Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015‐2016 season and comparison of HA mutations detected in Turkey since 2009</title><source>Wiley Online Library All Journals</source><creator>Guldemir, Dilek ; Coskun‐Ari, Fatma Filiz ; Altas, Ayse Basak ; Bakkaloglu, Zekiye ; Unaldi, Ozlem ; Bayraktar, Fatma ; Korukluoglu, Gulay ; Aktas, Ali Riza ; Durmaz, Riza</creator><creatorcontrib>Guldemir, Dilek ; Coskun‐Ari, Fatma Filiz ; Altas, Ayse Basak ; Bakkaloglu, Zekiye ; Unaldi, Ozlem ; Bayraktar, Fatma ; Korukluoglu, Gulay ; Aktas, Ali Riza ; Durmaz, Riza</creatorcontrib><description>Influenza A(H1N1)pdm09 pandemic virus causing the 2009 global outbreak moved into the post‐pandemic period, but its variants continued to be the prevailing subtype in the 2015‐2016 influenza season in Europe and Asia. To determine the molecular characteristics of influenza A(H1N1)pdm09 isolates circulating during the 2015‐2016 season in Turkey, we identified mutations in the hemagglutinin (HA) genes and investigated the presence of H275Y alteration in the neuraminidase genes in the randomly selected isolates. The comparison of the HA nucleotide sequences revealed a very high homology (&gt;99.5%) among the studied influenza A(H1N1)pdm09 isolates, while a relatively low homology (96.6%‐97.2%), was observed between Turkish isolates and the A/California/07/2009 vaccine virus. Overall 14 common mutations were detected in HA sequences of all 2015‐2016 influenza A(H1N1)pdm09 isolates with respect to the A/California/07/2009 virus, four of which located in three different antigenic sites. Eleven rare mutations in 12 HA sequences were also detected. Phylogenetic analysis revealed that all characterized influenza A(H1N1)pdm09 isolates formed a single genetic cluster, belonging to the genetic subclade 6B.1, defined by HA amino acid substitutions S84N, S162N, and I216T. Furthermore, all isolates showed an oseltamivir‐sensitive genotype, suggesting that Tamiflu (Oseltamivir) could still be the drug of choice in Turkey.</description><identifier>ISSN: 0146-6615</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/jmv.25565</identifier><identifier>PMID: 31389035</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>2015‐2016 influenza season ; Amino acids ; Antigens ; Antiviral drugs ; Exo-a-sialidase ; Genes ; Genotypes ; hemagglutinin ; Hemagglutinins ; Homology ; Influenza ; Influenza A ; influenza A(H1N1)pdm09 ; Mutation ; neuraminidase ; Nucleotides ; Oseltamivir ; oseltamivir resistance ; Pandemics ; Phylogeny ; Vaccines ; Virology ; Viruses</subject><ispartof>Journal of medical virology, 2019-12, Vol.91 (12), p.2074-2082</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3535-f73a705ae2eb4f107bd6b31da383f9e2d84c7de50a393ed79e07a6f26411e00d3</citedby><cites>FETCH-LOGICAL-c3535-f73a705ae2eb4f107bd6b31da383f9e2d84c7de50a393ed79e07a6f26411e00d3</cites><orcidid>0000-0001-6561-778X ; 0000-0002-8107-732X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjmv.25565$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjmv.25565$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31389035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guldemir, Dilek</creatorcontrib><creatorcontrib>Coskun‐Ari, Fatma Filiz</creatorcontrib><creatorcontrib>Altas, Ayse Basak</creatorcontrib><creatorcontrib>Bakkaloglu, Zekiye</creatorcontrib><creatorcontrib>Unaldi, Ozlem</creatorcontrib><creatorcontrib>Bayraktar, Fatma</creatorcontrib><creatorcontrib>Korukluoglu, Gulay</creatorcontrib><creatorcontrib>Aktas, Ali Riza</creatorcontrib><creatorcontrib>Durmaz, Riza</creatorcontrib><title>Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015‐2016 season and comparison of HA mutations detected in Turkey since 2009</title><title>Journal of medical virology</title><addtitle>J Med Virol</addtitle><description>Influenza A(H1N1)pdm09 pandemic virus causing the 2009 global outbreak moved into the post‐pandemic period, but its variants continued to be the prevailing subtype in the 2015‐2016 influenza season in Europe and Asia. To determine the molecular characteristics of influenza A(H1N1)pdm09 isolates circulating during the 2015‐2016 season in Turkey, we identified mutations in the hemagglutinin (HA) genes and investigated the presence of H275Y alteration in the neuraminidase genes in the randomly selected isolates. The comparison of the HA nucleotide sequences revealed a very high homology (&gt;99.5%) among the studied influenza A(H1N1)pdm09 isolates, while a relatively low homology (96.6%‐97.2%), was observed between Turkish isolates and the A/California/07/2009 vaccine virus. Overall 14 common mutations were detected in HA sequences of all 2015‐2016 influenza A(H1N1)pdm09 isolates with respect to the A/California/07/2009 virus, four of which located in three different antigenic sites. Eleven rare mutations in 12 HA sequences were also detected. Phylogenetic analysis revealed that all characterized influenza A(H1N1)pdm09 isolates formed a single genetic cluster, belonging to the genetic subclade 6B.1, defined by HA amino acid substitutions S84N, S162N, and I216T. Furthermore, all isolates showed an oseltamivir‐sensitive genotype, suggesting that Tamiflu (Oseltamivir) could still be the drug of choice in Turkey.</description><subject>2015‐2016 influenza season</subject><subject>Amino acids</subject><subject>Antigens</subject><subject>Antiviral drugs</subject><subject>Exo-a-sialidase</subject><subject>Genes</subject><subject>Genotypes</subject><subject>hemagglutinin</subject><subject>Hemagglutinins</subject><subject>Homology</subject><subject>Influenza</subject><subject>Influenza A</subject><subject>influenza A(H1N1)pdm09</subject><subject>Mutation</subject><subject>neuraminidase</subject><subject>Nucleotides</subject><subject>Oseltamivir</subject><subject>oseltamivir resistance</subject><subject>Pandemics</subject><subject>Phylogeny</subject><subject>Vaccines</subject><subject>Virology</subject><subject>Viruses</subject><issn>0146-6615</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp10UFu1DAYhmELgehQWHABZIlNu0j7247teDmqgAG1sClsLU_8R83gJIOdFE1XHIEzcLSepO6kdIHEypvHry19hLxmcMIA-Ommuz7hUir5hCwYGFUY0OwpWQArVaEUkwfkRUobAKgM58_JgWCiMiDkgvy5GALWU3CR1lcuunrE2N64sR16OjR0vELa9k2YsL9xdHm0Yp_Z8dZ3YGibhuBGTLQeQk6M6LPcX-DA5O2v3_lQNKFLOeV6n123dbFNc3m1pN007h9K1OP4WLic4nfc0dT29X0KzEvyrHEh4auH85B8ff_u8mxVnH_58PFseV7UQgpZNFo4DdIhx3XZMNBrr9aCeScq0Rjkvipr7VGCE0ag1wZBO9VwVTKGAF4ckqO5u43DjwnTaLs21RiC63GYkuVcGWEkMJbp23_oZphin39nuQBZlVIrndXxrOo4pBSxsdvYdi7uLAN7P5zNw9n9cNm-eShO6w79o_y7VAanM_jZBtz9v2Q_XXybk3fdTaHl</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Guldemir, Dilek</creator><creator>Coskun‐Ari, Fatma Filiz</creator><creator>Altas, Ayse Basak</creator><creator>Bakkaloglu, Zekiye</creator><creator>Unaldi, Ozlem</creator><creator>Bayraktar, Fatma</creator><creator>Korukluoglu, Gulay</creator><creator>Aktas, Ali Riza</creator><creator>Durmaz, Riza</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6561-778X</orcidid><orcidid>https://orcid.org/0000-0002-8107-732X</orcidid></search><sort><creationdate>201912</creationdate><title>Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015‐2016 season and comparison of HA mutations detected in Turkey since 2009</title><author>Guldemir, Dilek ; Coskun‐Ari, Fatma Filiz ; Altas, Ayse Basak ; Bakkaloglu, Zekiye ; Unaldi, Ozlem ; Bayraktar, Fatma ; Korukluoglu, Gulay ; Aktas, Ali Riza ; Durmaz, Riza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3535-f73a705ae2eb4f107bd6b31da383f9e2d84c7de50a393ed79e07a6f26411e00d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>2015‐2016 influenza season</topic><topic>Amino acids</topic><topic>Antigens</topic><topic>Antiviral drugs</topic><topic>Exo-a-sialidase</topic><topic>Genes</topic><topic>Genotypes</topic><topic>hemagglutinin</topic><topic>Hemagglutinins</topic><topic>Homology</topic><topic>Influenza</topic><topic>Influenza A</topic><topic>influenza A(H1N1)pdm09</topic><topic>Mutation</topic><topic>neuraminidase</topic><topic>Nucleotides</topic><topic>Oseltamivir</topic><topic>oseltamivir resistance</topic><topic>Pandemics</topic><topic>Phylogeny</topic><topic>Vaccines</topic><topic>Virology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guldemir, Dilek</creatorcontrib><creatorcontrib>Coskun‐Ari, Fatma Filiz</creatorcontrib><creatorcontrib>Altas, Ayse Basak</creatorcontrib><creatorcontrib>Bakkaloglu, Zekiye</creatorcontrib><creatorcontrib>Unaldi, Ozlem</creatorcontrib><creatorcontrib>Bayraktar, Fatma</creatorcontrib><creatorcontrib>Korukluoglu, Gulay</creatorcontrib><creatorcontrib>Aktas, Ali Riza</creatorcontrib><creatorcontrib>Durmaz, Riza</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guldemir, Dilek</au><au>Coskun‐Ari, Fatma Filiz</au><au>Altas, Ayse Basak</au><au>Bakkaloglu, Zekiye</au><au>Unaldi, Ozlem</au><au>Bayraktar, Fatma</au><au>Korukluoglu, Gulay</au><au>Aktas, Ali Riza</au><au>Durmaz, Riza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015‐2016 season and comparison of HA mutations detected in Turkey since 2009</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J Med Virol</addtitle><date>2019-12</date><risdate>2019</risdate><volume>91</volume><issue>12</issue><spage>2074</spage><epage>2082</epage><pages>2074-2082</pages><issn>0146-6615</issn><eissn>1096-9071</eissn><abstract>Influenza A(H1N1)pdm09 pandemic virus causing the 2009 global outbreak moved into the post‐pandemic period, but its variants continued to be the prevailing subtype in the 2015‐2016 influenza season in Europe and Asia. To determine the molecular characteristics of influenza A(H1N1)pdm09 isolates circulating during the 2015‐2016 season in Turkey, we identified mutations in the hemagglutinin (HA) genes and investigated the presence of H275Y alteration in the neuraminidase genes in the randomly selected isolates. The comparison of the HA nucleotide sequences revealed a very high homology (&gt;99.5%) among the studied influenza A(H1N1)pdm09 isolates, while a relatively low homology (96.6%‐97.2%), was observed between Turkish isolates and the A/California/07/2009 vaccine virus. Overall 14 common mutations were detected in HA sequences of all 2015‐2016 influenza A(H1N1)pdm09 isolates with respect to the A/California/07/2009 virus, four of which located in three different antigenic sites. Eleven rare mutations in 12 HA sequences were also detected. Phylogenetic analysis revealed that all characterized influenza A(H1N1)pdm09 isolates formed a single genetic cluster, belonging to the genetic subclade 6B.1, defined by HA amino acid substitutions S84N, S162N, and I216T. Furthermore, all isolates showed an oseltamivir‐sensitive genotype, suggesting that Tamiflu (Oseltamivir) could still be the drug of choice in Turkey.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31389035</pmid><doi>10.1002/jmv.25565</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6561-778X</orcidid><orcidid>https://orcid.org/0000-0002-8107-732X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0146-6615
ispartof Journal of medical virology, 2019-12, Vol.91 (12), p.2074-2082
issn 0146-6615
1096-9071
language eng
recordid cdi_proquest_miscellaneous_2269395011
source Wiley Online Library All Journals
subjects 2015‐2016 influenza season
Amino acids
Antigens
Antiviral drugs
Exo-a-sialidase
Genes
Genotypes
hemagglutinin
Hemagglutinins
Homology
Influenza
Influenza A
influenza A(H1N1)pdm09
Mutation
neuraminidase
Nucleotides
Oseltamivir
oseltamivir resistance
Pandemics
Phylogeny
Vaccines
Virology
Viruses
title Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015‐2016 season and comparison of HA mutations detected in Turkey since 2009
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T14%3A23%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20characterization%20of%20the%20influenza%20A(H1N1)pdm09%20isolates%20collected%20in%20the%202015%E2%80%902016%20season%20and%20comparison%20of%20HA%20mutations%20detected%20in%20Turkey%20since%202009&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Guldemir,%20Dilek&rft.date=2019-12&rft.volume=91&rft.issue=12&rft.spage=2074&rft.epage=2082&rft.pages=2074-2082&rft.issn=0146-6615&rft.eissn=1096-9071&rft_id=info:doi/10.1002/jmv.25565&rft_dat=%3Cproquest_cross%3E2305845767%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2305845767&rft_id=info:pmid/31389035&rfr_iscdi=true